- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00827827
Strength Training for Skeletal Muscle Adaptation After Stroke
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
This study investigates the hypothesis that a novel, high intensity, high repetition ST program will improve abnormalities in paretic and non-paretic leg muscle volume and composition compared to an attention-matched control regimen of supervised stretching over a 3-month intervention period in those disabled by stroke. The investigators further hypothesize that ST-induced skeletal muscle adaptation will translate into improved insulin sensitivity, strength, and function in this population. The specific objectives are to: 1) Determine the effects ST compared to a control intervention on paretic and non-paretic abnormalities in skeletal muscle volume, intramuscular fat, muscle fiber distribution, muscle capillary density, and muscle inflammation in chronically disabled stroke survivors. 2) Determine the effects ST compared to a control intervention on insulin sensitivity in stroke survivors, and whether structural and cellular skeletal muscle mechanisms contribute to improvements in insulin sensitivity after ST. 3) Determine the effects ST compared to a control intervention on physical function (strength, walking speed and balance) in stroke survivors, and whether structural skeletal muscle mechanisms predict ST-induced functional improvement.
The project design consists of 4 phases over 5 months for stroke participants enrolled in either of the two intervention arms (ST vs. CONTROL). During phase 1 the investigators will screen and consent chronic stroke patients with residual gait deficits. Phase 2 (3 weeks) will consist of baseline testing that includes dual energy X-ray absorptiometry (DEXA) scanning, bilateral CT scanning of the legs, bilateral vastus lateralis muscle biopsies, strength testing, timed walks, balance measurements, oral glucose tolerance testing, and hyperglycemic clamp testing. Following completion of baseline testing, volunteers are to be randomized to ST or the CONTROL group. Phase 3 (Intervention Phase, 3 months) will begin with 2 sessions of acclimatization for those assigned to the ST group. ST will then be progressed to 2 sets of 20 repetitions on each leg on each machine (Keiser Leg Press, Leg Extension, Leg Curl) with gradual increases in resistance over 3 months. Those in the CONTROL group will receive equal exposure to health care personnel in the Baltimore VA Exercise facility, performing a full battery of upper and lower body passive and active stretching exercises at each intervention session. In Phase 4 all baseline testing and laboratory analyses will be repeated.
Developing evidence-based therapies to combat skeletal muscle deterioration is highly relevant for chronically disabled stoke survivors. There is mounting evidence that current models of post-stroke rehabilitation are not optimal for maximizing recovery of muscle mass, strength, and metabolic health. The proposed research will develop new insight into the utility of progressive ST for reversing detrimental changes to gross muscle composition, muscle molecular phenotype, muscle inflammation, and muscle capillarization. Changes to any or all of these muscle parameters should have measurable impact on both whole body insulin sensitivity and function. Collectively, the results from this trial may change the current standard of care for stroke survivors by providing evidenced reasons for augmenting physical therapists' treatments, allowing more intense and diverse therapy sessions for maintenance of skeletal muscle.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Stroke greater than 6 months prior with residual hemiparetic gait in women or men aged 40-85 years
- Completion of all regular post-stroke physical therapy
- Adequate language and neurocognitive function to participate in testing and training and to give adequate informed consent
Exclusion Criteria:
- Alcohol consumption greater than 3 oz. liquor, or 3 x 4 oz glasses of wine, or 3 x 12 oz. beers per day, by self-report
clinical history of:
- unstable angina
- recent (less than 3 months) myocardial infarction or congestive heart failure (NYHA category II)
- hemodynamically significant valvular dysfunction
- peripheral arterial occlusive disease (PAOD) with claudication
- major orthopedic, chronic pain, or non-stroke neuromuscular disorders restricting exercise
- pulmonary or renal failure
- poorly controlled hypertension (greater than 190/110)
- recent hospitalization for severe disease or surgery
- severe or global receptive aphasia which confounds reliable testing and training
- Allergy to lidocaine
- Known muscle disorder
- Taking Coumadin or Lovenox (contraindication for muscle biopsies)
- Dementia
- Untreated major depression
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Arm 1
Participants in this group undergo lower-extremity strength training on three pneumatic resistance machines (Keiser Leg Press, Keiser Leg Extension, and Keiser Leg Curl).
Training sessions happen 3 times per week (M,W,F) and last approximately 45 minutes to 1 hour.
Participants in this group exercise each limb individually to account for the large discrepancies in strength between legs in stroke survivors.
|
3x per week lower-extremity ST lasting approximately 45 minutes to 1 hour.
|
|
Comparador Ativo: Arm 2
Participants in this group receive equal exposure to study staff compared with the experimental ST group (approximately 45 minutes to 1 hour 3 times per week).
Exercise sessions for this group involve a full battery of active and passive...upper and lower body...stretching and range of motion exercises performed on raised padded tables.
|
3x per week upper and lower body stretching mixed with active and passive range of motion exercises
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)
Prazo: Baseline, 3 months
|
Baseline, 3 months
|
|
|
Change in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)
Prazo: Baseline, 3 months
|
Baseline, 3 months
|
|
|
Change in 1-RM Muscle Strength (Leg Extension, Paretic Side)
Prazo: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)
Prazo: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in Leg Muscle Endurance (Paretic Side)
Prazo: Baseline, 3 Months
|
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
|
Baseline, 3 Months
|
|
Change in Leg Muscle Endurance (Non-Paretic Side)
Prazo: Baseline, 3 months
|
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
|
Baseline, 3 months
|
|
Change in 6-minute Walk Distance
Prazo: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in 10 Meter Walking Speed (Self-Selected)
Prazo: Baseline, 3 months
|
Baseline, 3 months
|
|
|
Change in 10 Meter Walking Speed (Fastest)
Prazo: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in Peak Aerobic Capacity (VO2 Peak)
Prazo: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in Berg Balance Scale
Prazo: Baseline, 3 months
|
This measure is a 14 item scale, with each item scored (0-4) and summed for a maximum score of 56 points.
Range is 0-56 and higher values represent a better outcome.
|
Baseline, 3 months
|
|
Change in Paretic Limb Step Time (Self-Selected)
Prazo: Baseline, 3 months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 months
|
|
Change in Paretic Limb Step Time (Fastest)
Prazo: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Non-Paretic Limb Step Time (Self-Selected)
Prazo: Baseline, 3 months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 months
|
|
Change in Non-Paretic Limb Step Time (Fastest)
Prazo: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Paretic Limb Step Length (Self-Selected)
Prazo: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Paretic Limb Step Length (Fastest)
Prazo: Baseline, 3 months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 months
|
|
Change in Non-Paretic Limb Step Length (Self-Selected)
Prazo: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Non-Paretic Limb Step Length (Fastest)
Prazo: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Ivey FM, Prior SJ, Hafer-Macko CE, Katzel LI, Macko RF, Ryan AS. Strength Training for Skeletal Muscle Endurance after Stroke. J Stroke Cerebrovasc Dis. 2017 Apr;26(4):787-794. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.018. Epub 2016 Nov 16.
- Ivey FM, Ryan AS. Resistive training improves insulin sensitivity after stroke. J Stroke Cerebrovasc Dis. 2014 Feb;23(2):225-9. doi: 10.1016/j.jstrokecerebrovasdis.2012.12.014. Epub 2013 Jan 22.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- B6737-R
- H30631 (Outro identificador: Baltimore VAMC)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .